An Opportunity to Donate Tissue: MRA Launches New Melanoma Biorepository to Advance Research
The Melanoma Research Alliance (MRA) is excited to announce the launch of a Melanoma Biorepository, a new initiative poised to accelerate melanoma research and improve health outcomes for patients with melanoma.
The MRA Melanoma Biorepository will exist as a growing resource for researchers that aims to:
- Enhance the timeliness and depth of research studies on melanoma biology,
- Identify new therapeutic targets,
- Advance the development of melanoma biomarkers.
Participants enrolled in the RARE Registry can now choose to donate tumor and normal tissue samples to the MRA Melanoma Biorepository, which will give qualified researchers access to high-quality specimens for research studies, especially those focused on acral and mucosal melanoma. Participants will also have an opportunity to connect their RARE Registry data with their donated tissue samples.
“The MRA Melanoma Biorepository solves one of the largest barriers to scientific progress for rare subtypes like acral and mucosal melanomas, which is the scarcity of patient samples. By providing timely access to a larger and more genetically diverse pool of patient samples, this resource will help accelerate scientific breakthroughs,” shared Dr. Jessica Scales (MRA’s Associate Director of Rare Melanoma Research).
To learn more about the MRA Melanoma Biorepository and how to donate, please visit our dedicated site, read MRA’s latest blog, or contact biorepository@curemelanoma.org.
